Eli Lilly's Zepbound Gains FDA Approval for Sleep Apnea
Eli Lilly's Zepbound secures FDA approval, becoming the first drug to treat sleep apnea in obese adults, shaking up the device market.
Eli Lilly's Zepbound received FDA approval as the first medicine to treat moderate-to-severe obstructive sleep apnea in adults with obesity.